FMP
Feb 04, 2026
Advanced Drainage Systems, Inc. (NYSE:WMS) is a prominent player in the water management industry, specializing in the design and production of thermoplastic corrugated pipes. Founded in 1966 and headquartered in Hilliard, Ohio, the company serves a diverse range of sectors, including non-residential, residential, agriculture, and infrastructure, across the United States, Canada, Mexico, and internationally.
The consensus price target for WMS has shown a positive trend, increasing from $181.57 last quarter to $184 last month. This upward movement suggests that analysts have a favorable outlook on the company's near-term prospects. The steady rise in the target price reflects growing confidence in the company's performance and potential growth.
Over the past year, the consensus price target for WMS has risen significantly from $168.08 to $184. This substantial increase indicates a strong belief in the company's future performance. The positive sentiment is further supported by the company's track record of surpassing earnings expectations, as highlighted by its recent earnings per share of $1.97, which exceeded the Zacks Consensus Estimate of $1.70.
Despite the positive consensus price target trend, analysts from Robert W. Baird have set a lower price target of $137 for WMS. This discrepancy may be due to differing views on the company's future performance or market conditions. However, the company's strong fundamentals and history of earnings growth suggest that it is well-positioned for continued success.
The recent Q2 2026 earnings call provided further insights into the company's financial performance and strategic direction. Key participants, including CEO D. Barbour and CFO Scott Cottrill, discussed the company's achievements and future plans. The positive earnings report and strategic insights reinforce the optimistic outlook for Advanced Drainage Systems, Inc.
Reinsurance Group of America, Incorporated (NYSE:RGA) is a leading global provider of traditional life and health reinsu...
AbbVie Inc. (NYSE: ABBV) is a global biopharmaceutical company known for its innovative treatments in immunology, oncolo...